FARALLON CAPITAL MANAGEMENT, L.L.C. - 30 Jun 2026 SCHEDULE 13G/A Report for AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares") (AGIO)

Filing manager
FARALLON CAPITAL MANAGEMENT, L.L.C.
Reporting owner
Farallon Capital Management, L.L.C.
Security
AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares")
Beneficially owned shares
5,917,400 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

9.9%

Beneficial ownership of this reported class.

Shares

5,917,400 shares

Shares beneficially owned as disclosed.

Event date

30 Jun 2026

Date tied to the ownership event or amendment.

Accepted by SEC

03 Aug 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
9.9%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
AGIO
Shares outstanding
59,771,717 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
03 Aug 2026, 08:30:11 UTC
Event date
30 Jun 2026
Source filing
View source filing

Key filing fact

FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 9.9% ownership in AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares") (AGIO) on 30 Jun 2026.

Key facts

  • FARALLON CAPITAL MANAGEMENT, L.L.C. filed SCHEDULE 13G/A for AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares") (AGIO).
  • Disclosed ownership: 9.9%.
  • Date of event: 30 Jun 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 03 Aug 2026, 08:30.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (29)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Farallon Capital Management, L.L.C. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Managing Member
Farallon Capital Partners, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Farallon Capital Institutional Partners, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Farallon Capital Institutional Partners II, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Farallon Capital Institutional Partners III, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Four Crossings Institutional Partners V, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Manager of its General Partner
Farallon Capital Offshore Investors II, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Farallon Capital (AM) Investors, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member of its General Partner
Farallon Capital F5 Master I, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Manager of its General Partner
Farallon Healthcare Partners Master, L.P. 0% 0 0 0 /s/ Hannah E. Dunn Manager of its General Partner
Farallon Partners, L.L.C. 0% 0 0 0 /s/ Hannah E. Dunn Managing Member
Farallon Institutional (GP) V, L.L.C. 0% 0 0 0 /s/ Hannah E. Dunn Manager
Farallon F5 (GP), L.L.C. 0% 0 0 0 /s/ Hannah E. Dunn Manager
Farallon Healthcare Partners (GP), L.L.C. 0% 0 0 0 /s/ Hannah E. Dunn Manager
Dapice Joshua J. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Dreyfuss, Philip D. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Dunn Hannah E. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Hannah E. Dunn
Gehani, Varun N. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Giauque, Nicolas 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Husen, Avner A. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Kim, David T. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Linn, Michael G. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Luo Patrick (Cheng) 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Roberts, Jr., Thomas G. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Saito Edric C. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Short Daniel S. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Spokes, Andrew J. M. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Warren, John R. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
Wehrly, Mark C. 9.9% 5,917,400 0 5,917,400 /s/ Hannah E. Dunn Attorney-In-Fact
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .